Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Assembly Biosciences Inc (NASDAQ:ASMB)

During the Trading Day
12.97 +0.14 / +1.09%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
12.97 0.00 / 0.00%
Volume: 348.00
Health Technology
Pharmaceuticals: Other

Company Description

Assembly Biosciences, Inc. operates as a biopharmaceutical company which develops novel treatments for hepatitis B virus infection and C. difficile-associated diarrhea. It specializes in the development of therapies for infectious diseases like HIV, CDAD and other disorders of the gastrointestinal system including of late-stage and pre-clinical prescription drugs and biologics. The company was founded on October 7, 2005 and is headquartered in New York, NY.

Contact Information

Assembly Biosciences, Inc.
99 Hudson Street
New York New York 10013
P:(646) 706-5208
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Derek A. SmallPresident, Chief Executive Officer & Director
David J. BarrettSecretary, Chief Operating & Financial Officer
Uri A. LopatinChief Medical Officer & Vice President
Lee D. ArnoldChief Scientific Officer
J. P. BenyaVice President-Business Development